BOLT BIOTHERAPEUTICS INC shareholders Q1 2023

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 42 filers reported holding BOLT BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

BOLT BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 1,166,952$1,622,0631.10%
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$2,629,1391.08%
Hawkeye Capital Management, LLC 415,039$576,9040.97%
Vivo Capital, LLC 3,871,291$5,381,0940.37%
TANG CAPITAL MANAGEMENT LLC 1,627,553$2,262,2990.34%
Newtyn Management, LLC 1,115,110$1,550,0030.30%
Samsara BioCapital, LLC 1,049,153$1,458,3230.30%
Sofinnova Investments, Inc. 2,754,437$3,828,6670.24%
Velan Capital Investment Management LP 140,000$194,6000.17%
Privium Fund Management (UK) Ltd 116,516$150,3060.12%
Board of Trustees of The Leland Stanford Junior University 719,546$1,000,1690.09%
Orbimed Advisors 1,541,000$2,141,9900.04%
Marquette Asset Management, LLC 97,835$135,9910.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,200$104,5280.00%
ADAGE CAPITAL PARTNERS GP, L.L.C. 500,000$695,0000.00%
Assenagon Asset Management S.A. 225,816$313,8840.00%
Citadel Advisors 2,838,445$3,945,4390.00%
Renaissance Technologies 456,739$6350.00%
BAILARD, INC. 28,500$39,6150.00%
WELLS FARGO & COMPANY/MN 151$2100.00%
External links

This page lists BOLT BIOTHERAPEUTICS INC's shareholders in Q1 2023. To view BOLT BIOTHERAPEUTICS INC's shareholder history, click here.